Search Results
All Content Formulary Only Other ContentWe have found 4 results when searching "Lisdexamfetamine"
PATHWAY
Attention deficit hyperactivity disorder (ADHD) : Treatment of ADHD
FORMULARY DECISION
Lisdexamfetamine : Elvanse
863/13 : As part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years of age and over when response to previous methylphenidate treatment...
FORMULARY DECISION
Lisdexamfetamine : Elvanse Adult
1079/15 : Indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in adults.